High Flow Oxygen VERSUS Non Invasive Ventilation Associated to Automated Flow Oxygen Titration After Patient Extubation (RespiFLOW)
Respiratory Disease
About this trial
This is an interventional treatment trial for Respiratory Disease focused on measuring High Flow Oxygen, Non Invasive Ventilation, Automated Flow Oxygen Titration, respiratory risk
Eligibility Criteria
Inclusion Criteria:
- Patient with respiratory disease suspected or proved (COPD, asthma, bronchiectasis, cystic fibrosis, interstitial pneumonia, obstructive insufficient respiratory, restrictive insufficient respiratory) when an extubation is scheduled.
- Patient who signed the informed consent
- Patient affiliated to social insurance
Exclusion Criteria:
- Pregnant woman
- Terminal extubation
- NIV at home before intubation (non-exclusion of continue positive airway pressure: CPAP)
- Tracheotomy
- Patient under trusteeship, guardianship or safeguard of justice
Sites / Locations
- CHU Larrey
Arms of the Study
Arm 1
Arm 2
Experimental
Active Comparator
High Flow Oxygen (HFO)
Non Invasive Ventilation (NIV)
HFO is a mix tap of air and oxygen. It permits to control FiO2 and generated controlled high flow air until 60/min. Air and oxygen are mixed, warmed, humidified and issued to patient by a warming monopod inspiratory circuit to nasal cannulas of a large diameter. Expiration is free.
NIV was already evaluated in post-extubation. This technic is now used in daily consolidation processing after extubation because it provides a ventilator help with two levels of pressure helping in respiratory work. Adding Automated Flow Oxygen Titration could optimized patient's oxygenation and reduce workload of caregivers